Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children

被引:39
|
作者
Ioannidou, S
Tassios, PT
Kotsovili-Tseleni, A
Foustoukou, M
Legakis, NJ
Vatopoulos, A
机构
[1] P&A Kyriakou Childrens Hosp, Dept Clin Microbiol, Athens, Greece
[2] Univ Athens, Sch Med, Dept Hyg & Epidemiol, Athens, Greece
关键词
viridans streptococci; MLSB resistance; children's oral flora;
D O I
10.1016/S0924-8579(00)00338-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A total of 200 isolates of viridans group streptococci isolated from the oropharynx of healthy Greek children were studied. Vancomycin, rifampicin, fluoroquinolones and dalfopristin/quinupristin were active against all tested isolates. High level resistance to gentamicin was not seen. Intermediate and high-level penicillin resistance was present in 28.5 and 14.5% isolates, respectively. with 41.3% of the latter group, being also resistant to cefotaxime. Resistance rates to other antimicrobials were as follows - erythromycin 38.5%, clarithromycin 33.5%, clindamycin 7.5% and tetracycline 23%. Penicillin resistance occurred more frequently in Streptococcus mitis isolates, while macrolide resistance was more frequent in S. oralis. MLSB resistance phenotype M was dominant (74%) among erythromycin resistant isolates, with phenotypes IR and CR being represented by 6 and 20% of isolates, respectively. (C) 2001 Elsevier Science B.V. and International Society of Chemotherapy All rights reserved.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 50 条
  • [41] Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci
    Ferrándiz, MJ
    Oteo, J
    Aracil, B
    Gómez-Garcés, JL
    de la Campa, AG
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) : 2520 - 2523
  • [42] Susceptibility, Resistance and Treatment Strategy for Infections Caused by Viridans Group Streptococci - A Review
    Dhotre, Shree V.
    Jahagirdar, Vilas L.
    Davane, Milind S.
    Nagoba, Basavraj S.
    JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2016, 5 (04) : 1 - 9
  • [43] Reemergence of macrolide resistance in pharyngeal isolates of group A streptococci in Southwestern Pennsylvania
    Green, M
    Martin, JM
    Barbadora, KA
    Beall, B
    Wald, ER
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 473 - 476
  • [44] Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes
    Westling, Katarina
    Julander, Inger
    Ljungman, Per
    Jalal, Shah
    Nord, Carl Erik
    Wretlind, Bengt
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (04) : 292 - 296
  • [45] Antimicrobial resistance of community-acquired bloodstream isolates of viridans group streptococci
    Yap, R. L.
    Mermel, L. A.
    Maglio, J.
    INFECTION, 2006, 34 (06) : 339 - 341
  • [46] Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance
    Cresti, S
    Lattanzi, M
    Zanchi, A
    Montagnani, F
    Pollini, S
    Cellesi, C
    Rossolini, GM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (06) : 1816 - 1822
  • [47] Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium
    Malhotra-Kumar, S
    Lammens, C
    Martel, A
    Mallentjer, C
    Chapelle, S
    Verhoeven, J
    Wijdooghe, M
    Haesebrouck, F
    Goossens, H
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) : 271 - 276
  • [48] Erythromycin resistance phenotypes in Swedish clinical isolates of group a streptococci
    Jasir, A
    Schalen, C
    STREPTOCOCCI AND THE HOST, 1997, 418 : 443 - 445
  • [49] Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis
    Quintero, Ana M.
    Vidal, Diego A. Cruz
    Klamer, Brett G.
    Ardura, Monica, I
    Oyeniran, Sophonie J.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2023, 12 (07) : 381 - 391
  • [50] Antibiotic resistance in faecal microbiota of Greek healthy infants
    Mitsou, E. K.
    Kirtzalidou, E.
    Pramateftaki, P.
    Kyriacou, A.
    BENEFICIAL MICROBES, 2010, 1 (03) : 297 - 306